Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Barrett

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
The New England Journal of Medicine|November 29, 1984
Breast cancer in mothers given diethylstilbestrol in pregnancyE R Greenberg, A B Barnes, L Resseguie, et al.
European Journal of Nuclear Medicine|May 11, 2000
Scintigraphic detection of acute experimental endocarditis with the technetium-99m labelled glycoprotein IIb/IIIa receptor antagonist DMP444W J Oyen, O C Boerman, F M Brouwers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patientsB D Cheson, J M Sorensen, D A Vena, et al.
Bioconjugate Chemistry|March 1, 1997
Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTcJ A Barrett, A C Crocker, D J Damphousse, et al.
Bioconjugate Chemistry|September 30, 1999
RP463: a stabilized technetium-99m complex of a hydrazino nicotinamide derivatized chemotactic peptide for infection imagingD S Edwards, S Liu, M C Ziegler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1997
Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammationC J van der Laken, O C Boerman, W J Oyen, et al.
Journal of Medicinal Chemistry|December 30, 2008
A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancerK P Maresca, S M Hillier, F J Femia, et al.
Clinical Rehabilitation|March 10, 2001
The COSTAR wheelchair study: a two-centre pilot study of self-propulsion in a wheelchair in early stroke rehabilitation. Collaborative Stroke Audit and ResearchJ A Barrett, C Watkins, R Plant, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
The New England Journal of Medicine|November 29, 1984
Breast cancer in mothers given diethylstilbestrol in pregnancyE R Greenberg, A B Barnes, L Resseguie, et al.
European Journal of Nuclear Medicine|May 11, 2000
Scintigraphic detection of acute experimental endocarditis with the technetium-99m labelled glycoprotein IIb/IIIa receptor antagonist DMP444W J Oyen, O C Boerman, F M Brouwers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patientsB D Cheson, J M Sorensen, D A Vena, et al.
Bioconjugate Chemistry|March 1, 1997
Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTcJ A Barrett, A C Crocker, D J Damphousse, et al.
Bioconjugate Chemistry|September 30, 1999
RP463: a stabilized technetium-99m complex of a hydrazino nicotinamide derivatized chemotactic peptide for infection imagingD S Edwards, S Liu, M C Ziegler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1997
Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammationC J van der Laken, O C Boerman, W J Oyen, et al.
Journal of Medicinal Chemistry|December 30, 2008
A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancerK P Maresca, S M Hillier, F J Femia, et al.
Clinical Rehabilitation|March 10, 2001
The COSTAR wheelchair study: a two-centre pilot study of self-propulsion in a wheelchair in early stroke rehabilitation. Collaborative Stroke Audit and ResearchJ A Barrett, C Watkins, R Plant, et al.
Pageof 12